Sohela S. is an accomplished Senior Scientist with a strong background in Next Generation Sequencing (NGS) and genetics. She has trained at prestigious institutions such as UCSF and Memorial Sloan Kettering and has over five years of commercial experience in scientific product development and collaborations. Sohela is passionate about using cutting-edge technologies and biology knowledge to enable effective disease management and treatment, as well as improving overall health and well-being.

Sohela has an impressive educational background, having studied Biochemistry at Rutgers University for her B.S. degree, followed by a Ph.D. in Genetics at Tufts University. She has also completed several programs to enhance her skills, such as programming for biology, Perl programming at Cold Spring Harbor Laboratory, and Genomic data analysis at Instituto di Ricerca Genetica e Biomedical.

Sohela's career includes several key roles such as her current position as Platform Development at Invitae where she focuses on genomics applications and solutions. Before joining Invitae, she served as Scientific Manager at MEDGENOME, leading research and clinical interpretation in genomics applications and solutions. She was also Research & Clinical Interpretation Lead and Scientific Relationships Manager at QIAGEN where she led the development of data analysis pipelines and oversaw collaborations.

Sohela has a wealth of experience, having previously held positions as Application Scientist at Ingenuity Systems, Postdoctoral Research Fellow at Memorial Sloan-Kettering Cancer Center, and Postdoctoral Scholar at UCSF. She is also a former member of the Complex Traits Consortium, demonstrating her interest in scientific collaborations and research.

In summary, Sohela S. is an accomplished scientist with a background in genetics, next-generation sequencing, and data analysis. Her extensive commercial experience, combined with her passion for using cutting-edge technologies and biological knowledge to improve disease management and treatment, make her a valuable asset in the scientific community.